SRD5A3 and neoplasm: Further analysis found that lentiviral-mediated SRD5A3 knockdown could overcome CDDP resistance in xenografts generated from T24R cells, as demonstrated by significantly reduced tumor growth in CDDP-treated xenografts than those without CDDP treatment (Fig. 3C).